BD India’s unveils ‘Safety-First’ initiative for healthcare workers

IMT News Desk
IMT News Desk
· 2 min read

More than 300 healthcare workers participated in the conference

BD India launched its Safety-First Initiative during the 11th Infusion Nurses Society (INS) annual conference in Kolkata. The initiative saw participation from over 300 healthcare workers.

BD India in collaboration with the Infusion Nurses Society conducted a panel discussion on Road to Zero Sharps Injuries where the panellists focussed on: 

  • Sharing methodology for successfully reaching the goal of zero needle stick injuries
  • Consensus that with the rapid technological advancements in healthcare delivery, it is vital to make healthcare professionals aware of safety-enabled devices.
  • The role of imparting adequate training to enable handling complex situations with ease and in accordance with key safety standards and protocols in infusion therapy.

In addition to the panel discussions on Safety-First, the winning team of the 7th edition of the BD INS Mastermind Quiz, namely Aster Medicity, Kochi was also felicitated on this occasion. This year, BD INS Mastermind Quiz saw participation from 12000+ nurses from hospitals across the country. The final five regional winning teams of two members each for the Grand Finale were from Max Hospital, Saket, New Delhi; The Mission Hospital, Durgapur; Fortis Hospital, Kalyan; Vasavi Trust Hospital, Bangalore and Aster Medicity, Kochi. 

Atul Grover, MD, BD India/South Asia, said, “Aligned with our purpose of Advancing the world of health, BD India’s Safety-First Initiative aims to provide a platform to early adopters of safety-engineered devices to share their journey towards driving the culture of safety in their healthcare delivery setup. We are happy to work with like-minded partners like INS at forums that provide a platform for knowledge sharing and best practices focused on the importance of safe and innovative technologies to enhance patient and healthcare workers’ safety.”

Col Binu Sharma, President, INS said, “Nurses are at the forefront of healthcare delivery. A safe working environment for nurses enhances the quality of care and improves patient outcomes. Infusion Nurses Society is committed to spreading awareness on Standard Infusion Practices across the country and we shall continue to raise awareness on prevention and management of needle stick injuries.”

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk